Jci_page_head_homepage_01 Jci_page_head_homepage_02
Min Li-Weber, Markus A. Weigand, Marco Giaisi, Dorothee Süss, Monika K. Treiber, Sven Baumann, Elena Ritsou, Raoul Breitkreutz, Peter H. Krammer
Published in Volume 110, Issue 5
J Clin Invest. 2002; 110(5):681 doi:10.1172/JCI15073
Abstract | Full text | PDF
Citation information

Total citations by year in CrossRef

Year: 2007 2005 2004 Total
Citations: 1 1 3 5

Citations to this article in CrossRef (5)

Title and authors Publication Year
Vitamin E succinate inhibits NF-κB and prevents the development of a metastatic phenotype in prostate cancer cells: Implications for chemoprevention
Paul L. Crispen, Robert G. Uzzo, Konstantin Golovine, Peter Makhov, Alan Pollack, Eric M. Horwitz, Richard E. Greenberg, Vladimir M. Kolenko
Prostate 2007
Considering Fas ligand as a target for therapy
Andreas Linkermann, Jing Qian, Marcus Lettau, Dieter Kabelitz, Ottmar Janssen
Expert Opin. Ther. Targets 2005
Anti-atherosclerotic effects of vitamin E ? myth or reality?
Adelina Munteanu, J.-M. Zingg, A. Azzi
Journal of Cellular and Molecular Medicine 2004
Combination therapy with vitamins C plus E inhibits survivin and human prostate cancer cell growth
Kushlani Gunawardena, L. David Campbell, A. Wayne Meikle
Prostate 2004
Vitamin E Inhibits Anti-Fas-Induced Phosphatidylserine Oxidation but Does Not Affect Its Externalization During Apoptosis in Jurkat T Cells and Their Phagocytosis by J774A.1 Macrophages
Behice F. Serinkan, Yulia Y. Tyurina, Hareesh Babu, Mirjana Djukic, Peter J. Quinn, Alan Schroit, Valerian E. Kagan
Antioxidants & Redox Signaling 2004